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The arginine-binding protein from Thermotoga maritima (TmArgBP) is an
arginine-binding component of the ATP-binding cassette (ABC) transport
system in this hyperthermophilic bacterium. This protein is endowed with an
extraordinary stability towards thermal and chemical denaturation. Its structural
characterization may provide useful insights for the clarification of structure–
stability relationships and for the design of new biosensors. Crystallization trials
were set up for both arginine-bound and ligand-free forms of TmArgBP and
crystals suitable for crystallographic investigations were obtained for both
forms. Ordered crystals of the arginine adduct of TmArgBP could only be
obtained by using the detergent LDAO as an additive to the crystallization
medium. These crystals were hexagonal, with unit-cell parameters a = 78.2,
c = 434.7 A˚, and diffracted to 2.7 A˚ resolution. The crystals of the ligand-free
form were orthorhombic, with unit-cell parameters a = 51.8, b= 91.9, c= 117.9 A˚,
and diffracted to 2.25 A˚ resolution.
1. Introduction
In many living organisms, the passage of small ligands through the
cell membrane is mediated by complex macromolecular assemblies
named ATP-binding cassettes (ABCs; Higgins, 1992; Oldham et al.,
2008). ABC transport systems constitute a large superfamily of
proteins which couple the hydrolysis of ATP to the passage of
metabolites through the cell membrane (Ethayathulla et al., 2008).
The expressed ABC transporters consist of two transmembrane
domains and two ATP-binding domains for the transportation of a
specific ligand across the membrane. In Gram-negative bacteria, each
transporter relies on a soluble periplasmic binding protein (PBP) that
is capable of interacting with a specific ligand essential for metabolic
and nutrient gathering (Davidson et al., 2008; Nanavati et al., 2005).
The PBPs associated with ABC transport systems are of remarkable
interest for the development of protein-based biosensors (de Lori-
mier et al., 2002; Marvin et al., 1997). Indeed, owing to the variety of
their binding specificities, they are currently utilized as designated
platforms for fluorescent protein biosensors for many naturally
occurring ligands (sugars, anions, amino acids etc.; Tolosa et al., 1999).
Moreover, re-engineering the binding site of these proteins as a
designed scaffold may significantly expand the number of small-
molecule analytes for which sensors may be generated. In this
framework, it is evident that proteins isolated from thermophilic
organisms possess added intrinsic value in the design of new
biosensing technologies that require enhanced stability.
Recently, we characterized a PBP that is involved in the amino-
acid transport system of Thermotoga maritima (Luchansky et al.,
2010; Scire` et al., 2010). Integrated biochemical and biophysical
characterization of this protein (hereafter referred to as TmArgBP)
has shown that it is an arginine-binding protein that is endowed with
remarkable structural stability even under strongly denaturating
conditions. Indeed, the native protein could not be denatured when
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heated to 373 K. Moreover, it is quite stable (Tm of 351 K) even when
treated with 6.0M guanidinium hydrochloride. On this basis, it has
been suggested that this ultrastable protein has the potential to be
exploited for the generation of durable and highly specific sensors for
arginine. The structural characterization of TmArgBP at the atomic
level will therefore be extremely useful for potential biotechnological
applications of this protein and for elucidation of the determinants of
its exceptional stability. Moreover, structural studies will also provide
useful insights into the interfaces involved in the mixture of oligo-
meric states (homodimers and homotrimers) detected for TmArgBP.
Here, we report the crystallization and preliminary crystallographic
investigations of TmArgBP.
2. Experimental methods
2.1. Cloning, expression and purification
In previous characterizations of TmArgBP, a construct presenting
an extension of 22 residues at the C-terminus, including a 6His-tag
motif, was used. To increase the crystallizability of the protein, a new
construct was prepared by the insertion of a stop codon that removes
this C-terminal extension. This construct, which was also deprived
of the signal sequence for perisplasmic export of the protein, corre-
sponds to the region 20–246 (227 residues) of the protein sequence
(UniProt code Q9WZ62). This sequence region was cloned into the
NdeI–BamHI site of a pET21a vector. The resulting positive plasmid
was used to transform Rosetta(DE3)pLysS competent cells. Expres-
sion of the protein was carried out using the transformed cells, which
were grown overnight at 310 K in LB containing 50 mg ml1 kana-
mycin and 30 mg ml1 chloramphenicol. When an OD600 of 0.6 was
reached, the cells were induced for 3 h with 0.5 mM IPTG.
The absence of the 6His affinity tag from the present TmArgBP
construct required some modifications of the protein-purification
protocol. The cells were resuspended in 20 mM Tris–HCl buffer
pH 8.0 containing a protease-inhibitor cocktail (Roche Diagnostic)
and sonicated. The cell debris was removed by centrifugation at
18 000 rev min1 for 40 min. The protein supernatant was initially
purified by thermoprecipitation (343 K water bath for 30 min). The
heat-denatured proteins were removed by centrifugation. The soluble
protein extract was loaded onto a 5 ml Resource Q column (Phar-
macia) equilibrated with Tris buffer pH 8.0. After washing with ten
volumes of buffer, a linear gradient of NaCl (0–500 mM) was applied
to elute the protein. The fractions containing TmArgBP were pooled
and dialyzed against a buffer consisting of 20 mM Tris–HCl pH 8.0,
150 mM NaCl at 277 K. After dialysis, the protein was concentrated
for further purification by size-exclusion chromatography on Super-
dex 200 (GE Healthcare; 50 mM Tris–HCl, 150 mM NaCl pH 8.0).
The homogeneity of the protein was evaluated by SDS–PAGE
analysis. The molecular mass of the purified protein (25 270 Da) was
checked by mass spectrometry and no proteolysis of the protein was
detected.
2.2. Crystallization experiments
Crystallization trials were performed at 293 K using the hanging-
drop vapour-diffusion method. A preliminary screening for crystal-
lization conditions was carried out using commercially available
sparse-matrix kits (Crystal Screen, Crystal Screen 2 and Index from
Hampton Research; Jancarik & Kim, 1991). Optimization of the
crystallization conditions was performed by fine-tuning the protein
and precipitant concentrations and by the use of crystallization
additives (Additive Screen from Hampton Research; McPherson et
al., 2011).
2.3. Data collection and processing
Preliminary diffraction data for both the apo and holo forms of
TmArgBP were collected in-house at 100 K using a Rigaku Micro-
Max-007 HF generator producing Cu K radiation and equipped
with a Saturn944 CCD detector. This equipment was also used for
crystallization communications
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Table 1
Data-collection parameters and data-processing statistics.
Values in parentheses are for the highest resolution shell.
HoloTmArgBP ApoTmArgBP
Radiation source Beamline X12,
EMBL/DESY
In-house rotating anode
Wavelength (A˚) 1.000 1.5418
Crystal-to-detector distance (mm) 260 55
Oscillation angle per frame () 0.10 0.50
Crystal symmetry and presumed
space group
Hexagonal, P622 Orthorhombic, P212121
Unit-cell parameters (A˚) a = 78.2, b = 78.2,
c = 434.7
a = 51.8, b = 91.9,
c = 117.9
Resolution (A˚) 50.0–2.70 (2.80–2.70) 50.0–2.25 (2.33–2.25)
Mean multiplicity 3.2 4.7
Completeness (%) 94.0 (79.7) 89.7 (85.5)
Total reflections 68279 115134
Unique reflections 21612 24691
Rmerge† 0.124 (0.356) 0.126 (0.242)
Mean I/(I) 11.6 (2.7) 14.0 (5.2)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
the ith measurement of reflection hkl and hI(hkl)i is the mean value of the intensity of
reflection hkl.
Figure 1
(a) Crystals of HoloTmArgBP grown in 17%(w/v) PEG 10 000, 0.1M bis-tris pH
5.5, 0.1M ammonium acetate. The crystals shown in (b) were grown under the same
conditions with the addition of LDAO detergent [0.5%(v/v)].
the collection of the diffraction data from the apo form. Data were
collected at 100 K from crystals cryoprotected by adding a solution of
14%(v/v) ethylene glycol to the precipitating solution. Diffraction
data for the holo form of TmArgBP were collected on the X12
synchrotron beamline at the DORIS storage ring, DESY (Hamburg,
Germany) using a MAR225 CCD detector at 100 K from crystals
cryoprotected by adding 14%(v/v) ethylene glycol to the precipitating
solution. The diffraction data were collected using a small rotation
angle of 0.1 and a crystal-to-detector distance of 260 mm owing to
the long c axis.
All data sets were scaled and merged using theHKL-2000 program
package (Otwinowski & Minor, 1997). Statistics of data collection are
reported in Table 1.
3. Results and discussion
Previous characterizations of TmArgBP have clearly indicated that
the protein purifies as a complex with arginine. Analysis of the
thermal stability of the TmArgBP sample obtained using the purifi-
cation procedure adopted here demonstrates that it also corresponds
to the arginine-bound complex (HoloTmArgBP). The protein does
not unfold in aqueous solutions when heated to 373 K. Thermal
denaturation was observed at 351 K when 6.0M guanidinium hydro-
chloride was added to the solution, in line with previous analyses
carried out on the arginine-bound complex.
An initial screening of commercially available solutions provided
promising crystallization conditions for HoloTmArgBP in the pre-
sence of PEG 10 000 as a precipitant. The size and morphology of the
HoloTmArgBP crystals were improved by fine-tuning the concen-
trations of the protein and the precipitating agent. Crystals that were
suitable for diffraction experiments were obtained using vapour-
diffusion techniques and a protein concentration of 20–25 mg ml1.
The composition of the reservoir solution was 17%(w/v) PEG 10 000,
0.1M ammonium acetate, 0.1M bis-tris buffer pH 5.5. Despite their
good morphology (Fig. 1a), these crystals were highly disordered, as
shown by their fibre-like diffraction pattern (Fig. 2a). In order to
improve the quality of these crystals, a number of additives were
added to the crystallization drops. Long rod-shaped crystals (0.05 
0.1  0.6 mm) were obtained using 0.5%(w/v) n-dodecyl-N,N-di-
methylamine-N-oxide (LDAO) as an additive (Fig. 1b). These
crystals reached their optimal size in 1 d. Analysis of the diffraction
pattern exhibited by these new crystals clearly indicated that the
additive greatly improved the crystal quality (Fig. 2b). Indexing of the
crystallization communications
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Figure 2
Diffraction patterns of HoloTmArgBP crystals obtained in the absence (a) or in the
presence (b) of the additive LDAO.
Figure 3
Crystals of ApoTmArgBP grown in the presence of (a) 20%(w/v) PEG 3350, 0.1M
HEPES pH 7.5, 0.15M ammonium acetate and (b) 20%(w/v) PEG MME 2000,
0.1M Tris–HCl pH 8.5, 0.2M trimethylamine N-oxide dihydrate.
diffraction pattern demonstrated that these crystals present a very
long unit-cell axis (435 A˚; Fig. 2b and Table 1). To avoid overlaps
of diffraction spots, a long crystal-to-detector distance (260 mm) was
used for data collection. Moreover, although the long axis of the
crystal was almost parallel to the spindle axis, we prudently used a
small oscillation range (0.1). The crystals presented a primitive
hexagonal symmetry. Statistics of data processing and scaling are
reported in Table 1, assuming space group P622. Matthews coefficient
calculations (Matthews, 1968) suggest the presence of either three
(VM = 2.5 A˚
3 Da1, 51% solvent content) or four (VM = 1.9 A˚
3 Da1,
35% solvent content) molecules per asymmetric unit.
The apo form of the protein (ApoTmArgBP) was prepared using
the procedure reported by Luchansky et al. (2010). Briefly, the
protein was incubated with 6.0M guanidinium hydrochloride under
dialysis for 3 d. The denaturant was removed by dialysis (Luchansky
et al., 2010) against a solution consisting of 20 mM Tris–HCl, 150 mM
NaCl pH 8.0. The melting temperature (336 K) of this protein sample
in 6.0M guanidinium hydrochloride was virtually identical to that
exhibited by the apo form in previous studies (Luchansky et al., 2010).
Crystallization screenings performed using commercial kits led to the
identification of several promising crystallization conditions. Crystals
suitable for X-ray diffraction testing were obtained using either
20%(w/v) PEG 3350, 0.1M HEPES pH 7.5, 0.15M ammonium
acetate or 20%(w/v) PEG MME 2000, 0.1M Tris–HCl pH 8.5, 0.2M
trimethylamine N-oxide dihydrate (Figs. 3a and 3b) as precipitating
solutions. In both cases the protein concentration was in the range
15–20 mg ml1. The crystals obtained from the solution containing
PEGMME 2000 displayed a poor diffraction pattern (lower than 6 A˚
resolution) despite their good morphology (Fig. 3b). In contrast, the
crystals obtained using PEG 3350 as precipitant proved to be suitable
for crystallographic data collection (Fig. 4). These crystals reached
their optimal size within one week. The crystals were orthorhombic,
with unit-cell parameters a = 51.8, b= 91.9, c= 117.9 A˚, and diffracted
to 2.25 A˚ resolution (Table 1). Matthews coefficient calculations
suggested the presence of two molecules (VM = 2.8A˚
3 Da1, 56%
solvent content) per asymmetric unit (Matthews, 1968).
Attempts to solve the structures of both the apo and holo forms of
the protein are in progress. In particular, models of ArgBP isolated
from Salmonella typhimurium (Stamp et al., 2011) and Geobacillus
stearothermophilus (Vahedi-Faridi et al., 2008), which share 37%
sequence identity with TmArgBP, are being used in the trials. As
molecular-replacement trials may be complicated by the large unit
cell of the holo form and by the intrinsic flexibility of amino-acid-
binding proteins in their ligand-free state, selenomethionine deriva-
tives of TmArgBP are being prepared.
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Figure 4
Diffraction pattern of ApoTmArgBP crystals grown in 20%(w/v) PEG 3350, 0.1M
HEPES pH 7.5, 0.15M ammonium acetate.
